GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » PB Ratio

Dechra Pharmaceuticals (LSE:DPH) PB Ratio : 5.83 (As of Apr. 30, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-30), Dechra Pharmaceuticals's share price is £38.66. Dechra Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2023 was £6.63. Hence, Dechra Pharmaceuticals's PB Ratio of today is 5.83.

The historical rank and industry rank for Dechra Pharmaceuticals's PB Ratio or its related term are showing as below:

LSE:DPH' s PB Ratio Range Over the Past 10 Years
Min: 2.94   Med: 5.34   Max: 9.17
Current: 5.83

During the past 13 years, Dechra Pharmaceuticals's highest PB Ratio was 9.17. The lowest was 2.94. And the median was 5.34.

LSE:DPH's PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.94 vs LSE:DPH: 5.83

During the past 12 months, Dechra Pharmaceuticals's average Book Value Per Share Growth Rate was 7.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 14.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dechra Pharmaceuticals was 115.80% per year. The lowest was 4.00% per year. And the median was 19.75% per year.

Back to Basics: PB Ratio


Dechra Pharmaceuticals PB Ratio Historical Data

The historical data trend for Dechra Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals PB Ratio Chart

Dechra Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.54 4.82 7.47 5.62 5.56

Dechra Pharmaceuticals Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.47 9.03 5.62 3.54 5.56

Competitive Comparison of Dechra Pharmaceuticals's PB Ratio

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dechra Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's PB Ratio falls into.



Dechra Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dechra Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=38.66/6.631
=5.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Dechra Pharmaceuticals  (LSE:DPH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Dechra Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dechra Pharmaceuticals (LSE:DPH) Business Description

Traded in Other Exchanges
Address
24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines